This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 4.3% to $10.30 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 25,114.44 and the Dow Jones Industrial Average falling 0.3% to 49,499.27.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 49.9% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 1.4% to $7.00, Fortress Biotech Inc. rose 1.3% to $2.33, and Viking Therapeutics Inc. fell 3.78% to $30.00.
Trading volume totaled 532,689, compared to the 50-day average of 239,517.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 01, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.